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Editorial on the Research Topic
The Chemistry of Imaging Probes
Over the past decades, the field of molecular imaging (MI) has been rapidly growing
involving multiple disciplines such as medicine, biology, chemistry, pharmacology and biomedical
engineering. An in vivo MI protocol non-invasively provides visual and quantitative information
on normal or pathological processes at the cellular or sub-cellular level. Currently, molecular
imaging can be performed in the clinical environment via Magnetic Resonance Imaging (MRI),
Optical Imaging (OI), Positron Emission Tomography (PET), Single-Photon Emission Computed
Tomography (SPECT), Computed Tomography (CT) and Ultrasound (US). Each of these imaging
modalities has its own advantages and disadvantages, and therefore, a multimodal approach
combining two techniques is often adopted to generate complementary anatomical and functional
information of the disease (Anderson and Lewis, 2017).
The key requirement for any molecular imaging procedure is a chemical agent, called the
imaging probe. This probe typically consists of two chemical entities: one that produces a signal
for imaging and another, a targeting vector, which enables the probe to specifically visualize,
characterize and quantify biological processes in living systems. The optimization of the probes
involves several different aspects ranging from the design of imaging units that exhibit enhanced
sensitivity and lower toxicity, to the control of the structural and electronic features of the targeting
moiety responsible for the molecular recognition (Long andWong, 2015). In this research topic we
present a series of original research and review articles that summarize the chemistry of molecular
imaging, both in terms of optimization of the MI probe and in terms of application of different
imaging techniques such as MRI, PET/SPECT, OI, and US.
The optimization of MRI contrast agents (CAs) is pursued to obtain more stable, safer
and more efficient probes for potential application in molecular imaging. In particular, two
dinuclear Gd(III) complexes and their relaxometric characterization have been reported by Leone
et al. demonstrating that a significant contribution of second sphere water molecules is responsible
for the strong relaxivity enhancement observed over a large range of magnetic field strengths.
Regarding Mn(II) complexes of 12-membered macrocyclic ligands as a promising alternative
to Gd-based CAs, Tircsó et al. have reviewed the relationship between ligand structure and
physicochemical properties of the complexes. The rigidity of the macrocycle and proper selection
of the donor atoms in the sidearm are the key structural features that control the thermodynamic
and the dissociation kinetic properties of these macrocyclic Mn(II) complexes.
The synthesis, characterization and handling of Eu(II)-containing complexes have been
reviewed by Basal and Allen showing how these air-sensitive probes can provide an
intriguing and promising approach to new MRI molecular imaging procedures. The review
especially focuses on the reduction of Eu(III) to produce Eu(II)-containing complexes and
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on the handling of Eu(II)-containing samples to prevent
oxidation and obtain accurate data.
Chemical Exchange Saturation Transfer (CEST) continues
to attract increasing attention as an alternative MR imaging
modality to T1 shortening agents. A contribution from
Farashishiko et al. reports on an attempt to improve the
sensitivity of these agents by incorporating a large payload
of paraCEST agents into a reverse-assembled nanocapsule.
Unfortunately, the result was not an amplification of the CEST
effect, but quenching of the signal, attributed to an increase of
the transverse relaxation rate of chelate protons caused by slow
molecular tumbling of the complex in the nanosized system.
19F-containing imaging probes can be advantageously
employed in MRI and Magnetic Resonance Spectroscopy (MRS)
because virtually there is no background 19F MR signal in vivo.
In the present topic, theories and strategies of improving the
sensitivity of 19F probes with paramagnetic metal ions have been
reviewed by Peterson et al. In particular, the paper focuses on a
theory that predicts the impact of certain molecular parameters
on the sensitivity of fluorine-based probes.
The in vivo application of MRI—theranostic probes whose
activation is induced by ultrasound, thermal or mechanical
effects (sonosensitive probes) has been reviewed by Garello and
Terreno. This work shows how these probes can be used for real-
time monitoring of triggered drug release. These liposome based
nano/microvesicles are composed of a biocompatible membrane
responsive to US and an aqueous core loaded with a MRI probe
and a therapeutic agent. A significantly better therapeutic effect
was observed using US triggered drug release in comparison to
traditional therapies.
The investigation of the luminescence properties of a Tb(III)-
DOTA-calix[4]arene derivative was carried out by Mayer et al.
with the aim to design dual MR/optical imaging probes. The
paper shows how the calix[4]arene core with its four aromatic
rings acts as an effective sensitizer of Tb-centred luminescence
but different substituents on the lower rim can cause micellar
aggregation leading to a significant decrease in the intensity of
Tb(III) luminescence.
A dual-modality iron oxide nanoplatform for in vivo targeted
SPECT and MRI investigation of tumor vascularization has
been developed by Tsoukalas et al. The NPs were coated with
99mTc radiolabeled Bevacizumab (BCZM)monoclonal antibodies
(specific affinity to vascular endothelial growth factor—VEGF-
A—receptor). Initial in vivo SPECT and MRI studies revealed
the suitability of Fe3O4-DMSA-SMCC-BCZM for targeted dual-
modality imaging.
The use of conjugates comprised of more than one
targeting biomolecule (multimers) is a well-established and
straightforward way to enhance the target affinity and uptake
of radiotherapeutics. For this purpose, Wurzer et al. designed
a DOTA-tetraphosphinate chelator (DOTPI) possessing
four terminal carboxylic acid moieties to obtain tetrameric
bioconjugates. The favorable properties of the 177Lu labeled
tetrameric DOTPI(PSMA)4 conjugates for targeted radionuclide
therapy have been demonstrated in in vitro and in vivo studies.
In order to rationalize the influence of metal ion
contamination [e.g., Ti(IV), Fe(III), Cu(II), Zn(II) or Al(III)] on
68Ga labeling, the physicochemical properties of Ga(TRAP) and
Fe(TRAP) (TRAP = triazacyclononane phosphinic acid) were
investigated in detail by Vágner et al. Equilibrium and kinetic
data showed that the stability constants and the dissociation rates
of Ga(III)- and Fe(III)-complexes are very similar. However, the
slower formation of Fe(TRAP) allows selective labeling of TRAP
with 68Ga(III) even in presence of Fe(III) contamination in the
eluate.
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